[Phase III additional clinical study of 111In-pentetreotide (MP-1727): diagnosis of gastrointestinal hormone producing tumors based on the presence of somatostatin receptors].
Saga T, Tamaki N, Itoi K, Yamazaki T, Endo K, Watanabe G, Maruno H, Machinami R, Koizumi K, Ichikawa T, Takami H, Ishibashi M, Kubo A, Kusakabe K, Hirata Y, Murata Y, Miyachi Y, Tsubuku M, Sakahara H, Katada K, Tonami N, Yamamoto K, Konishi J, Imamura M, Doi R, Shimatsu A, Noguchi S, Hasegawa Y, Ishikawa O, Watanabe Y, Nakajo M.
Saga T, et al. Among authors: endo k.
Kaku Igaku. 2003 May;40(2):185-203.
Kaku Igaku. 2003.
PMID: 12884785
Clinical Trial.
Japanese.